Navigating the Glofitamab CRL and Bispecifics’ Place in Lymphoma
Written by
Cancer Network
Published
0
comments
0
min
Tycel Phillips, MD, spoke about the impact the glofitamab CRL had on the landscape of bispecifics in lymphoma.